1. Drug and device manufacturer communications with payors, formulary committees, and similar entities: questions and answers : guidance for industry and review staff Publication: Silver Spring, MD : Center for Drug Evaluation and Research, June 2018 Subject(s): CommunicationEquipment and Supplies -- economicsInsurance, Health, Reimbursement -- economicsPharmaceutical Preparations -- economicsTruth DisclosureCosts and Cost AnalysisDevice ApprovalDrug ApprovalDrug IndustryInformation DisseminationOutcome Assessment (Health Care) -- economicsHumansUnited StatesUnited States. Department of Health and Human Services.United States. Food and Drug Administration.
